European Healthtech startup funding raised during Q2 2011.
In Q2 2011, 23 European Healthtech companies raised a combined €119M across 23 funding rounds, down 10.3% versus Q2 2010. UK led by capital raised, and Enterprise Ireland was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Oxford Nanopore Technologies | Series D+ | Apr 2011 | €28M |
| GenKyoTex | Series C | May 2011 | €14M |
| BONESUPPORT | Growth/Late | Jun 2011 | €13M |
| LifeBond | Series C |
| May 2011 |
| €13M |
| Sapiens | Series A | Jun 2011 | €13M |
| OrSense | Growth/Late | May 2011 | €12M |
| Mendor | Series B | Jun 2011 | €8.1M |
| Craneware | Early VC | Jun 2011 | €4.2M |
| Nexstim | Other | May 2011 | €2.0M |
| STAT-Diagnostica | Series A | Jun 2011 | €2.0M |
| Crescent Diagnostics | Series A | Jun 2011 | €1.5M |
| Lophius | Growth/Late | Jun 2011 | €1.4M |
| Simplee | Seed | Apr 2011 | €1.3M |
| Abcam | Early VC | Jun 2011 | €1.3M |
| Scint-X | Other | May 2011 | €1.1M |
